Biocydex Competitors and Similar CompaniesClear all
Rigel Pharmaceuticals's competitors and similar companies include Fortrea.
 Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | |
Founding Date | Founding Date 1996 | Founding Date 2023 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more |
Employees | Employees 1633% increase | Employees 19,000 |
Valuation ($) | Valuation ($) 256 m | Valuation ($) 1.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $294.3m (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) |
Net income | Net income $367m (FY, 2025) | Net income ($986.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Fortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company